Education
About Us
Working with TipRanks
Follow Us
Anagenics Limited (AU:AN1)
ASX:AN1
AN1 Stock Chart & Stats
Currently, no data available
Please return soon. This page is being updated.
---
Anagenics News
PremiumCompany Announcements
Anagenics Limited to Resume Trading on ASXPremiumCompany Announcements
Anagenics Limited Outlines Strategic Growth Plans Post-Restructuring
PremiumCompany Announcements
Anagenics Limited Releases Corporate Governance Statement
PremiumCompany Announcements
Anagenics Limited Reports Improved Net Operating Performance in 3Q25
PremiumCompany Announcements
Anagenics Limited Reports Quarterly Cash Flow with Strategic BorrowingPremiumCompany Announcements
Anagenics Limited Announces Change in Substantial ShareholdingPremiumCompany Announcements
FOS Capital Becomes Substantial Holder in Anagenics Limited
PremiumCompany Announcements
Anagenics Limited Announces Cessation of Securities---
Options Prices
Currently, No data available
---
Ownership Overview
1.86% Insiders
―
Mutual Funds
― Other Institutional Investors
98.14% Public Companies and
Individual Investors
AN1 FAQ
What was Anagenics Limited’s price range in the past 12 months?
Currently, no data Available
What is Anagenics Limited’s market cap?
Anagenics Limited’s market cap is AU$3.69M.
When is Anagenics Limited’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Anagenics Limited’s earnings last quarter?
Anagenics Limited released its earnings results on Feb 27, 2025. The company reported -AU$0.001 earnings per share for the quarter, missing the consensus estimate of N/A by -AU$0.001.
Is Anagenics Limited overvalued?
According to Wall Street analysts Anagenics Limited’s price is currently Overvalued.
Does Anagenics Limited pay dividends?
Anagenics Limited does not currently pay dividends.
What is Anagenics Limited’s EPS estimate?
Anagenics Limited’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Anagenics Limited have?
Currently, no data Available
What happened to Anagenics Limited’s price movement after its last earnings report?
Anagenics Limited reported an EPS of -AU$0.001 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went same N/A.
Which hedge fund is a major shareholder of Anagenics Limited?
Currently, no hedge funds are holding shares in AU:AN1
---
Anagenics Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Blogger Sentiment
Bearish
AU:AN1 Sentiment 67%
Sector Average 67%
Sector Average 67%
News Sentiment
Neutral
Bullish news 50%
Bearish news 100%
Bearish news 100%
Fundamentals
Return on Equity
-135.49%
Trailing 12-Months
Asset Growth
-61.98%
Trailing 12-Months
Company Description
Anagenics Limited
Anagenics Limited operates as a health and beauty-tech company in Australia, New Zealand, Japan, and internationally. The company develops and sales FGF5 inhibitor hair health and hair growth products under the evolis, evolis Professional, Lexilis Hybrid, Jo-Ju RED, and Lexilis BLACK brands. It markets its products through various channels, including e-commerce, television shopping, wholesale pharmacy and salons, and cross border export markets. The company was formerly known as Cellmid Limited and changed its name to Anagenics Limited in December 2021. Anagenics Limited was incorporated in 2004 and is based in Sydney, Australia.
---
Cynata Therapeutics Limited
―
―
IDT Australia Limited
―
Botanix Pharmaceuticals Limited
―
Star Combo Pharma Ltd.
―
---